ISRCTN85575959已完成未知
A phase III, multicentre, single blind, randomised controlled trial in the use of hyperbaric oxygen therapy versus biofeedback therapy in patients with chronic faecal incontinence associated with pudendal neuropathy
Department of Health (UK)0 个研究点目标入组 100 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •100 patients, 50 on each arm.
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
不适用
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-DECELLERIX, S.L.207
进行中（未招募）
不适用
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-NLCELLERIX, S.L.207
进行中（未招募）
1 期
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I)EUCTR2006-003370-95-ESCELLERIX, S.L.207
已完成
3 期
Comparison of Olmesartan +Amlodipine +Hydrochlorothiazide combination with Olmesartan +Hydrochlorothiazide combination in essential hypertension.CTRI/2010/091/006071Aristo Pharmaceuticals Pvt. Ltd. 23-Off veera desai road, Andheri W Mumbai-400053220
进行中（未招募）
1 期
A multicenter clinical trial to compare the efficacy and safety of Casirivimab and Imdevimab or Bamlanivimab and Etesevimab or Sotrovimab in high risk COVID-19 hospital admission patients.Mild to moderate COVID-19 patients at high risk of progression to severe COVID-19 and / or hospitalizationMedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-004266-35-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA552